
NITO Valuation
N2OFF Inc
NITO Relative Valuation
NITO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NITO is overvalued; if below, it's undervalued.
Historical Valuation
N2OFF Inc (NITO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.94 is considered Fairly compared with the five-year average of 0.00. The fair price of N2OFF Inc (NITO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:3.20
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
4.96
EV/EBITDA
N2OFF Inc. (NITO) has a current EV/EBITDA of 4.96. The 5-year average EV/EBITDA is 0.17. The thresholds are as follows: Strongly Undervalued below -4.36, Undervalued between -4.36 and -2.10, Fairly Valued between 2.43 and -2.10, Overvalued between 2.43 and 4.69, and Strongly Overvalued above 4.69. The current Forward EV/EBITDA of 4.96 falls within the Strongly Overvalued range.
5.30
EV/EBIT
N2OFF Inc. (NITO) has a current EV/EBIT of 5.30. The 5-year average EV/EBIT is 0.20. The thresholds are as follows: Strongly Undervalued below -4.60, Undervalued between -4.60 and -2.20, Fairly Valued between 2.60 and -2.20, Overvalued between 2.60 and 5.00, and Strongly Overvalued above 5.00. The current Forward EV/EBIT of 5.30 falls within the Strongly Overvalued range.
0.94
PS
N2OFF Inc. (NITO) has a current PS of 0.94. The 5-year average PS is 5.05. The thresholds are as follows: Strongly Undervalued below -11.31, Undervalued between -11.31 and -3.13, Fairly Valued between 13.23 and -3.13, Overvalued between 13.23 and 21.41, and Strongly Overvalued above 21.41. The current Forward PS of 0.94 falls within the Historic Trend Line -Fairly Valued range.
7.52
P/OCF
N2OFF Inc. (NITO) has a current P/OCF of 7.52. The 5-year average P/OCF is 0.49. The thresholds are as follows: Strongly Undervalued below -6.39, Undervalued between -6.39 and -2.95, Fairly Valued between 3.93 and -2.95, Overvalued between 3.93 and 7.38, and Strongly Overvalued above 7.38. The current Forward P/OCF of 7.52 falls within the Strongly Overvalued range.
6.92
P/FCF
N2OFF Inc. (NITO) has a current P/FCF of 6.92. The 5-year average P/FCF is 0.36. The thresholds are as follows: Strongly Undervalued below -6.13, Undervalued between -6.13 and -2.89, Fairly Valued between 3.60 and -2.89, Overvalued between 3.60 and 6.85, and Strongly Overvalued above 6.85. The current Forward P/FCF of 6.92 falls within the Strongly Overvalued range.
N2OFF Inc (NITO) has a current Price-to-Book (P/B) ratio of 1.31. Compared to its 3-year average P/B ratio of 0.74 , the current P/B ratio is approximately 76.63% higher. Relative to its 5-year average P/B ratio of -1.05, the current P/B ratio is about -223.87% higher. N2OFF Inc (NITO) has a Forward Free Cash Flow (FCF) yield of approximately -41.15%. Compared to its 3-year average FCF yield of -112.01%, the current FCF yield is approximately -63.26% lower. Relative to its 5-year average FCF yield of -79.25% , the current FCF yield is about -48.08% lower.
1.31
P/B
Median3y
0.74
Median5y
-1.05
-41.15
FCF Yield
Median3y
-112.01
Median5y
-79.25
Competitors Valuation Multiple
The average P/S ratio for NITO's competitors is 2.74, providing a benchmark for relative valuation. N2OFF Inc Corp (NITO) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 50.58%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NITO decreased by 54.96% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 43.83K to 66.00K.
The secondary factor is the Margin Expansion, contributed 1.51%to the performance.
Overall, the performance of NITO in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

KPRX
Kiora Pharmaceuticals Inc
2.250
USD
-2.39%

MBIO
Mustang Bio Inc
1.220
USD
-2.40%

BMRA
Biomerica Inc
2.500
USD
-0.79%

UGRO
urban-gro Inc
0.284
USD
-7.50%

SEED
Origin Agritech Ltd
1.460
USD
+3.47%

MI
Nft Ltd
3.360
USD
-10.18%

LCFY
Locafy Ltd
3.950
USD
0.00%

DLPN
Dolphin Entertainment Inc
1.600
USD
-4.19%

PMCB
PharmaCyte Biotech Inc
0.816
USD
-4.11%
FAQ
Is N2OFF Inc (NITO) currently overvalued or undervalued?
N2OFF Inc (NITO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.94 is considered Fairly compared with the five-year average of 0.00. The fair price of N2OFF Inc (NITO) is between to according to relative valuation methord.









